SVP Research @ Five Prime Therapeutics, Inc. (May 2014 - August 2017)
Scientific Director @ (July 2002 - May 2014)
Scientist @ (September 1996 - July 2002)
Post-doctoral scientist @ (January 1995 - January 1996)
Luis Borges Education
University of Washington - School of Medicine
Ph.D (Department of Pathology)
1990-1995
University of Lisbon
Marine Biology (Marine Biology)
1980-1985
Luis Borges Skills
Monoclonal Antibodies
Lifesciences
Antibodies
Drug Discovery
Biotechnology
Immunology
Cell Culture
In Vivo
Biomarkers
ELISA
Drug Development
Biopharmaceuticals
Assay Development
Oncology
Molecular Biology
In Vitro
Cell
Immunotherapy
Biologics
Hematology
Animal Models
Cancer Research
Cancer
Inflammation
Biomarker Discovery
Immunoassays
Toxicology
Life Sciences
Science
Customer Service
Pharmaceutical Industry
Project Management
Program Management
Leadership
Luis Borges Summary
Luis Borges, based in Houston, TX, US, is currently a Founder and CEO, Artemia Therapeutics at Artemia therapeutics. Luis Borges brings experience from previous roles at Borges Biotech Advisors LLC, Shinobi Therapeutics, Metagenomi and Century Therapeutics. Luis Borges holds a 1990 - 1995 Ph.D in Department of Pathology @ University of Washington - School of Medicine. With a robust skill set that includes Monoclonal Antibodies, Lifesciences, Antibodies, Drug Discovery, Biotechnology and more. Luis Borges has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Luis Borges?
Find contact details for 700 million professionals.